[go: up one dir, main page]

DK128285A - Cyclosporinderivater - Google Patents

Cyclosporinderivater Download PDF

Info

Publication number
DK128285A
DK128285A DK128285A DK128285A DK128285A DK 128285 A DK128285 A DK 128285A DK 128285 A DK128285 A DK 128285A DK 128285 A DK128285 A DK 128285A DK 128285 A DK128285 A DK 128285A
Authority
DK
Denmark
Prior art keywords
cyclosporin derivatives
cyclosporin
derivatives
Prior art date
Application number
DK128285A
Other languages
Danish (da)
English (en)
Other versions
DK128285D0 (da
Inventor
Roland Wenger
Rene P Traber
Hans Kobel
Hans Hofmann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK128285D0 publication Critical patent/DK128285D0/da
Publication of DK128285A publication Critical patent/DK128285A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK128285A 1984-03-23 1985-03-21 Cyclosporinderivater DK128285A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (2)

Publication Number Publication Date
DK128285D0 DK128285D0 (da) 1985-03-21
DK128285A true DK128285A (da) 1985-09-24

Family

ID=26287502

Family Applications (1)

Application Number Title Priority Date Filing Date
DK128285A DK128285A (da) 1984-03-23 1985-03-21 Cyclosporinderivater

Country Status (24)

Country Link
US (1) US4639434A (xx)
JP (1) JPH08838B2 (xx)
AT (1) AT388737B (xx)
BE (1) BE901980A (xx)
CA (1) CA1247546A (xx)
CH (1) CH667274A5 (xx)
CS (1) CS249542B2 (xx)
DE (1) DE3509809A1 (xx)
DK (1) DK128285A (xx)
ES (1) ES8702926A1 (xx)
FI (1) FI851120L (xx)
FR (1) FR2561651B1 (xx)
GB (1) GB2155936B (xx)
GR (1) GR850716B (xx)
HU (1) HU200786B (xx)
IL (1) IL74681A (xx)
IT (1) IT1199962B (xx)
LU (1) LU85819A1 (xx)
NL (1) NL8500828A (xx)
NO (1) NO851160L (xx)
NZ (1) NZ211526A (xx)
PH (2) PH21868A (xx)
PT (1) PT80149B (xx)
SE (1) SE461334B (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587342T2 (de) 1984-10-04 1993-12-02 Sandoz Ag Cyclosporine.
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
EP0373260B1 (en) * 1987-06-22 1994-03-09 Merck & Co. Inc. Cyclosporin derivatives with modified "8-amino acid"
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
EP0391909B1 (en) * 1987-09-03 1994-08-17 The University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
CH679119A5 (xx) * 1988-05-13 1991-12-31 Sandoz Ag
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
ES2095926T5 (es) * 1990-11-02 2001-02-16 Novartis Ag Cyclosporins.
ATE142344T1 (de) * 1990-11-20 1996-09-15 Behringwerke Ag Immunotest für cyclosporin
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
RU2170741C2 (ru) * 1996-08-16 2001-07-20 Новартис Аг Способ получения циклоспорина
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
DE69840586D1 (de) 1997-10-08 2009-04-02 Isotechnika Inc Deuterierte Cyclosporin-analoga und ihre Verwendung als immunmodulierende Agenzien
US5990274A (en) * 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
ATE332917T1 (de) * 2001-10-19 2006-08-15 Isotechnika Inc Synthese von cyclosporin-analogen
PT1435910E (pt) * 2001-10-19 2009-09-07 Isotechnika Inc Novos pré-concentrados de microemulsão de análogos da ciclosporina
WO2004082629A2 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
JP2008514702A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
US7378391B2 (en) * 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
US7361636B2 (en) * 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
KR102011339B1 (ko) 2010-12-15 2019-08-16 콘트라빌 파마슈티컬스, 인코퍼레이티드 아미노산 1 및 3에서 변형된 사이클로스포린 유사체 분자
WO2012125569A2 (en) 2011-03-11 2012-09-20 Beth Israel Deaconess Medical Center, Inc. Anti-cd40 antibodies and uses thereof
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
SI3307322T1 (sl) 2015-09-04 2021-08-31 Primatope Therapeutics Inc. Humanizirana protitelesa proti CD40 in njihove uporabe

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3260468D1 (en) * 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine

Also Published As

Publication number Publication date
IL74681A0 (en) 1985-06-30
FR2561651A1 (fr) 1985-09-27
ES8702926A1 (es) 1987-01-16
NL8500828A (nl) 1985-10-16
DK128285D0 (da) 1985-03-21
FR2561651B1 (fr) 1990-03-09
HUT38370A (en) 1986-05-28
ATA86385A (de) 1989-01-15
CA1247546A (en) 1988-12-28
SE8501392L (sv) 1985-09-24
IT8547852A1 (it) 1986-09-22
CS249542B2 (en) 1987-03-12
CH667274A5 (de) 1988-09-30
DE3509809A1 (de) 1986-01-09
NO851160L (no) 1985-09-24
IT8547852A0 (it) 1985-03-22
BE901980A (fr) 1985-09-23
FI851120A7 (fi) 1985-09-24
PH21868A (en) 1988-03-25
IT1199962B (it) 1989-01-05
HU200786B (en) 1990-08-28
FI851120L (fi) 1985-09-24
US4639434A (en) 1987-01-27
PT80149B (en) 1987-03-23
PT80149A (en) 1985-04-01
IL74681A (en) 1989-09-10
LU85819A1 (fr) 1985-12-12
SE8501392D0 (sv) 1985-03-21
PH23357A (en) 1989-07-14
GR850716B (xx) 1985-07-19
GB2155936A (en) 1985-10-02
GB8507270D0 (en) 1985-04-24
JPS60215700A (ja) 1985-10-29
SE461334B (sv) 1990-02-05
NZ211526A (en) 1988-08-30
ES541465A0 (es) 1987-01-16
FI851120A0 (fi) 1985-03-20
JPH08838B2 (ja) 1996-01-10
GB2155936B (en) 1987-09-16
AT388737B (de) 1989-08-25

Similar Documents

Publication Publication Date Title
DK128285D0 (da) Cyclosporinderivater
DK268285A (da) Dialkoxypyridinderivater
DK35785D0 (da) Tetrahydrocarbazolonderivater
DK243985A (da) Aminoalkylphenoxyderivater
DE3463503D1 (de) Sulfonamido-benzamide derivatives
DK400485A (da) Cyclosporinterapi
DE3566887D1 (de) Flavanon derivatives
DK524585D0 (da) Cholecalciferolderivater
DK443685D0 (da) Pirimidinderivater
DK320585A (da) Fluorallylaminderivater
AT386724B (de) Haecksler
ES539508A0 (es) Derivados de androsteno nuevos
DK514585A (da) Aminoethylanilinderivater
ATA237384A (de) Maehwerk
DE3565100D1 (de) Cycloalkane-indene-carboximidamide derivatives
DK267190A (da) 13-substitueret-5-ketomilbemycinderivater
ATE36715T1 (de) 7-d-mandelamido-3-(1-sulfomethyltetrazol-5us840229
BR8505778A (pt) Dentifricio adstringente
BR8407371A (pt) Microinterruptor
BR8407345A (pt) Micromutador
DK54085A (da) Phenylpropargylaminderivater
DE3564269D1 (de) Eburnane derivatives
NO1997011I1 (no) Tacrolimus
ES529437A0 (es) Derivados de 3-pirrolidinopropiofenona
ES277139Y (es) Complejo mueble-bar-nevera

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment